CLOUDBREAK THERAPEUTICS LLC
IPOSeeing Life Better Through Medicine
IRVINE, United States · Founded 2018
- Headquarters
- IRVINE, California
- Employees
- 1–10
- Founded
- 2018
- Business Model
- B2B
- Website
- cloudbreakpharma.com
- Last Round
- Series C
- Rounds
- 5
About
Cloudbreak Pharma is a clinical-stage ophthalmic biopharmaceutical company developing topical eye drop treatments for chronic eye diseases with limited therapeutic options. Their lead candidate CBT-001, a multi-kinase inhibitor, targets pterygium and related anterior segment diseases. The company has licensing partnerships with Santen Pharmaceutical and Grand Pharma.
Summary
CLOUDBREAK THERAPEUTICS LLC is a Biotech company based in IRVINE, United States, founded in 2018. Investors include National Institutes of Health and DYEE Capital.
Tech & App Stack
3 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Funding History
Sep 2025
Sign up to see all 6 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company